Hide Board Information

Show Board Information

Renaissancere 6.08 C RNR-C

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/29/2012 7:30:55 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Renaissancere 6.08 C (NYSE: RNR-C) Stock Message Board

1. RNR-C Company Profile

    

2. RNR-C Time & Sales

    

3. RNR-C Recent News

    

4. RNR-C Filings

    

5. RNR-C Financials

    

6. RNR-C Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Renaissancere 6.08 C RNR-C

Recent Articles

• Solo Brands, Inc. Faces Challenges Yet Sees Growth in Q2 Results
• Rathbones Group's Position in Empiric Student Property Plc Explained
• Stack Capital Group Inc. Unveils Impressive Q2 Financial Milestones
• Clearway Energy Launches $100 Million Equity Offering Program
• Insight into Apax Global Alpha's Position Disclosure Process
• Understanding the Opening Position Disclosure for Assura Plc
• FOXO Technologies Pursues New Horizons with Care Facility Deal
• Shamal Holding's Naïa Island: The Future of Luxury Living
• Discover the Top Oversold Stocks for Growth in the Market
• Transforming Organizations: Zhang Ruimin's Visionary Approach
• Amadria Park Enhances Guest Experiences with Shiji Tech
• OppFi Sees Record Growth in Revenue and Adjusted Income Guidance
• Sunstone Hotel Investors Declares Q2 2025 Financial Results
• Vishay Intertechnology's Strong Second Quarter Performance
• eHealth, Inc. Showcases Robust Financial Growth in Recent Quarter
• Broadridge and Uptiq: Revolutionizing Wealth Management with AI
• DeFi Technologies Reports Strong Asset Growth and Market Expansion
• Zoomcar Partners with Google Cloud to Transform Guest Experience
• Helix Acquisition Corp. II Retains Majority Trust Funds Post-Redemptions
• Leadership Change at Proven Behavior Solutions: A New Era Begins
• Growing Trends in the Lawn and Garden Consumables Market
• Matador Technologies Expands Bitcoin Influence Through Events
• Innovative Manufacturing Expansion of NFI’s Alexander Dennis
• EyePoint Pharmaceuticals to Share Insights at Upcoming Conference
• Lexicon Pharmaceuticals Unveils Financial Growth and Updates
• Trade Uncertainty Rises with New Agreements and Deadlines
• Forte Minerals Enhances Capital Team with Advisors and New Tools
• Orezone Gold Corporation Successfully Launches ASX Listing
• Exploring Arbutus Biopharma's Financial Success and Future Ahead
• Innovative Food Holdings Prepares for Anticipated Q2 Earnings Call
• Zevra Therapeutics Shares Insights at Esteemed Annual Conference
• Pokémon Cards Dramatically Outperforming Traditional Investments
• Nexxen International Ltd. to Showcase Innovations in Finance
• Holley Performance Achieves Growth in Second Quarter Results
• MannKind Secures $500 Million Financing for Growth Initiatives
• Shamal Holding's Naïa Island: A New Era in Luxury Living
• Diebold Nixdorf Achieves Outstanding Performance in Q2 Financials
• McDonald's Q2 2025 Financial Highlights and Insights
• Breakthrough Research on Novel Tularemia Vaccine ATI-1701
• Arch Biopartners Progresses in Groundbreaking Kidney Injury Trial
• Renoworks Software Reports Impressive Growth and Future Goals
• Kornit Digital Achieves Steady Growth Amid Challenges
• Aurora Cannabis Reports Impressive Q1 2026 Financial Results
• First Quantum Minerals Launches Tender Offer for Senior Notes
• Sunoco LP's Impressive Q2 2025 Financial Highlights
• Sprott's Financial Performance for Q2 2025 Highlights Growth
• Purple Biotech: Transforming Cancer Treatment with Innovation
• Avista Corp's Q2 2025 Performance Report Highlights Growth
• Ceragon Networks' Q2 2025 Financial Results Summary
• MannKind Corporation's Financial Overview and Business Prospects